Annual Grant Award Dollars
| Investigator | Title | Sponsor | ID | Dates | Amount |
| Alister J Bates | Improving Outcomes in Pediatric Obstructive Sleep Apnea with Computational Fluid Dynamics | National Institutes of Health (NIH) | K99HL144822 | 09/01/2019 - 08/31/2020 | $153,171 |
| Anil Goud Jegga DVM Anjaparavanda Naren, PHD John Paul Clancy, MD |
Preclinical characterization of saracatinib for cystic fibrosis therapy | National Institutes of Health (NIH) | UG3 TR002612 | 09/01/2019 - 08/31/2020 | $212,000 |
| Anjaparavanda Naren, PHD | Personalizing Cystic Fibrosis Research Translation | Cystic Fibrosis Foundation | Naren19R0 | 07/01/2019 - 06/30/2020 | $600,000 |
| Anjaparavanda Naren, PHD | LPA2 receptor-containing complexes in regulating secreto | National Institutes of Health (NIH) | R01DK093045 | 07/01/2019 - 06/30/2020 | $351,000 |
| Anjaparavanda Naren, PHD | Transporters and hematopoietic toxicity | St Jude's Children's Hospital (National Institutes of Health) | R01CA194206 | 07/01/2019 - 06/30/2020 | $28,595 |
| Anjaparavanda Naren, PHD John Paul Clancy, MD Jeffrey A Whitsett, MD |
Personalized Cystic Fibrosis Therapy and Research Center | National Institutes of Health (NIH) | P30DK117467 | 07/01/2019 - 06/30/2020 | $775,380.67 |
| Assem Ziady, PHD | Longitudinal Study of Cystic Fibrosis Liver Disease | University of Colorado (Cystic Fibrosis Foundation ) | NARKEW16AB0 | 01/01/2019 - 12/31/2019 | $10,342 |
| Barbara A Chini, MD | First and Second year Clinical Fellowship | Cystic Fibrosis Foundation | 0001077 | 07/01/2019 - 06/30/2020 | $66,750 |
| Christopher Siracusa, MD | Design CF: Developing e-Health Systems to Improve Growth and Nutrition in CF (Phase II) | Children's Hospital Boston (Cystic Fibrosis Foundation ) | CHB;Siracusa | 06/01/2018 - 12/31/2019 | $124,271 |
| Christopher Siracusa, MD | Success with Therapies Research Consortium | Cystic Fibrosis Foundation | SIRACU15PE0 | 08/01/2019 - 07/31/2020 | $32,400 |
| Christopher Siracusa, MD | Reducing Stress & Incorporating Wellness Around New Diagnosis in CF | Cystic Fibrosis Foundation | SIRACU18QI0 | 08/01/2019 - 07/31/2020 | $43,200 |
| Duncan E Keegan, MD | First and Second Year Clinical Fellowship | Cystic Fibrosis Foundation | KEEGAN19B0 | 07/01/2019 - 06/30/2020 | $61,750 |
| Elizabeth L Kramer, MD-PHD | The Role of TGF in Driving Airway Hyperresponsiveness and Smooth Muscle Dysfunction in Cystic Fibrosis | Cystic Fibrosis Research, Inc. | Cystic Fib - Kramer, | 06/01/2019 - 05/31/2020 | $70,000 |
| Gary McPhail, MD | Cystic Fibrosis Center Program Accreditation And Funding | Cystic Fibrosis Foundation | CC160-130 | 07/01/2019 - 06/30/2020 | $167,845 |
| Gary McPhail, MD | Improving P. aeruginosa detection in non-expectorators via breath testing | Dartmouth College (Cystic Fibrosis Foundation ) | R1021 | 04/01/2019 - 03/31/2020 | $16,164 |
| Gary McPhail, MD | Improving outcomes in CF patients: Toward rapid detection of P. aeruginosa | Dartmouth College (National Institutes of Health) | R1069 | 09/01/2019 - 08/31/2020 | $25,027 |
| Jason C Woods, PHD | Hyperpolarized Imaging for New Therapies (HyPOINT) in Pediatric CF | Cystic Fibrosis Foundation | CFF Woods | 08/01/2019 - 07/31/2020 | $774,379 |
| Jason C Woods, PHD | MRI Phenotyping of Early BPD and Prediction of Outcomes | National Institutes of Health (NIH) | R01HL146689 | 04/01/2020 - 03/31/2021 | $774,028 |
| Jason C Woods, PHD | A Phase III Trial to Validate HP 129Xe MRI as a Function | Polarean Inc. (National Institutes of Health) | R44HL123299 | 04/01/2019 - 03/31/2020 | $427,039 |
| Jason C Woods, PHD Raouf Samy Amin, MD |
UTE MRI to monitor CF lung disease and response to CFTR | National Institutes of Health (NIH) | R01HL131012 | 04/01/2020 - 03/31/2021 | $703,064 |
| John J Brewington, MD | Personalized Model Systems to Predict/Investigate CFTR Drug Response in CF | Cystic Fibrosis Foundation | CFF_Brewington | 08/01/2019 - 07/31/2020 | $50,000 |
| John J Brewington, MD | Personalized Model Systems to Predict and Investigate CFTR Drug Response in CF | National Institutes of Health (NIH) | K08HL144825 | 08/01/2019 - 07/31/2020 | $163,620 |
| John Paul Clancy, MD | Losartan as anti-inflammatory therapy to augment F508del CFTR recovery | University of Miami (Cystic Fibrosis Foundation ) | SPC-000389 | 04/01/2019 - 09/30/2019 | $44,836 |
| KYU SHIK MUN | Patient-derived Pancreatic Duct-on-a-chip to study CFTR Channel Function | Cystic Fibrosis Foundation | Mun CFF Fellowship | 04/01/2019 - 03/31/2020 | $65,450 |
| Laura L Walkup, PHD | Early detection of regional BOS in BMT patients using UTE and 129Xe MRI | National Institutes of Health (NIH) | R00HL138255 | 04/01/2020 - 03/31/2021 | $249,000 |
| Michael Seid, PHD | CF Learning Network: Implementation Phase | Cystic Fibrosis Foundation | SEID19AB0 | 01/01/2020 - 12/31/2020 | $2,918,242 |
| Naga Gowthama Sarma Mylavarapu, PHD | Development of Virtual Surgery Technology Platform for Obstructive Sleep Apnea | Department of Defense | W81XWH1910043 | 05/01/2019 - 10/31/2020 | $261,950 |
| Neil Stewart | Rapid, multi-functional MRI for infant lung disease | Thrasher Research Fund | Thrasher_Stewart | 01/01/2020 - 12/31/2020 | $13,375 |
| Raouf Samy Amin, MD | Upper Airway Structure and Function and Risk for OSA in Children with Down Syndrome | Albert Einstein College of Medicine (National Institutes of Health) | 311427 | 05/01/2019 - 04/30/2020 | $29,481 |
| Raouf Samy Amin, MD | Therapeutic Development Center Award | Cystic Fibrosis Foundation | CLANCY14Y0 | 01/01/2019 - 03/31/2020 | $24,631 |
| Raouf Samy Amin, MD | Additional Research Coordinator (ARC) Award | Cystic Fibrosis Foundation | CLANCY14Y4 | 12/01/2018 - 03/31/2021 | $7,266 |
| Raouf Samy Amin, MD | Pulmonary Vascular Disease in Cystic Fibrosis | Cystic Fibrosis Foundation | AMIN19A0 | 01/01/2020 - 12/31/2020 | $372,691 |
| Satish K Madala, PHD | Therapeutic Benefit of Hsp90 Inhibition in Pulmonary Fib | Department of Defense Army | W81XWH-17-1-0666 | 09/30/2019 - 09/29/2020 | $583,135 |
| Satish K Madala, PHD | IL-31 Regulation of Immunopathology in Pulmonary Fibrosis | National Institutes of Health (NIH) | R21AG059533 | 05/01/2019 - 04/30/2021 | $206,290 |
| Stacey Ishman, MD-MPH | Positive airway pressure for the treatment of obstructive sleep apnea syndrome in children with Down syndrome. | Children's Hospital of Philadelphia (National Institutes of Health) | 3201930820 | 09/23/2019 - 08/31/2020 | $133,765 |
| Theresa Guilbert, MD-MS | ORBEX: Primary Prevention of Asthma and Wheezing in Children | University of Arizona (National Institutes of Health) | PO 438886 | 05/01/2019 - 04/30/2020 | $143,122 |
| Theresa Guilbert, MD-MS | ORBEX: Primary Prevention of Asthma and Wheezing in Children | University of Arizona (National Institutes of Health) | PO 438886 | 03/31/2020 - 04/30/2020 | $300,000 |
| Theresa Guilbert, MD-MS | Vitamin D to prevent Severe Asthma Exacerbations in High-Risk Children-CCC | University of Pittsburgh (National Institutes of Health) | 0045031 (130888-6) | 06/01/2018 - 05/31/2020 | $13,330 |
| Vishwaraj Chandrakanth Sontake | MOLECULAR MECHANISMS OF PULMONARY FIBROSIS INCYSTIC FIBROSIS | Cystic Fibrosis Foundation | Sontake CFF | 04/01/2019 - 03/31/2020 | $65,450 |
| William D Hardie, MD | Serum Biomarkers of Pulmonary Fibrosis Induction, Progression and Resolution | Cleveland Clin Lerner Col of Med of CWRU (National Institutes of Health) | 1159-SUB | 01/01/2019 - 02/29/2020 | $119,250 |
| Zackary Cleveland, PHD | Validating Quantitative Magnetic Resonance Imaging Biomarkers of Idiopathic Pulmonary Fibrosis. | National Institutes of Health (NIH) | R01HL143011 | 01/01/2020 - 12/31/2020 | $771,092 |
| Current Year Direct | $11,952,381.67 | ||||
Annual Industry Award Dollars
| Investigator | Industry Sponsor | Amount |
| Assem Ziady, PHD | Spark Therapeutics, Inc. | $34,321.00 |
| Christopher Towe, MD | Boehringer Ingelheim Pharmaceuticals | $53,108.00 |
| Gary McPhail, MD | Boehringer Ingelheim Pharmaceuticals | $166,961.00 |
| Gary McPhail, MD | Vertex Pharmaceutical Incorporated | $755,276.00 |
| Hemant Sawnani, MD | Santhera Pharmaceuticals Inc. | $43,350.00 |
| Jason C Woods, PHD | University of Cincinnati (Polarean Inc.) | $58,894.00 |
| Satish K Madala, PHD | Daewoong Pharmaceutical Co., Ltd | $74,449.00 |
| Sheharyar Durrani, MD | Astrazeneca | $163,500.00 |
| Sheharyar Durrani, MD | Sanofi Pasteur Biologics, LLC | $146,174.00 |
| Total Annual Industry Award Dollars | $1,496,033.00 | |
